IceCure Medical Ltd (ICCM)
IceCure Medical Ltd Statistics
Share Statistics
IceCure Medical Ltd has 56.57M shares outstanding. The number of shares has increased by 18% in one year.
| Shares Outstanding | 56.57M |
| Shares Change (YoY) | 18% |
| Shares Change (QoQ) | 3.27% |
| Owned by Institutions (%) | 0.31% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 7,884 |
| FTD / Avg. Volume | 2.56% |
Short Selling Information
The latest short interest is 233.58K, so 0.4% of the outstanding shares have been sold short.
| Short Interest | 233.58K |
| Short % of Shares Out | 0.4% |
| Short % of Float | 4.77% |
| Short Ratio (days to cover) | 1.32 |
Valuation Ratios
The PE ratio is -3.53 and the forward PE ratio is -10.38. IceCure Medical Ltd's PEG ratio is 1.13.
| PE Ratio | -3.53 |
| Forward PE | -10.38 |
| PS Ratio | 16.45 |
| Forward PS | 0.8 |
| PB Ratio | 7.85 |
| P/FCF Ratio | -4.29 |
| PEG Ratio | 1.13 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for IceCure Medical Ltd.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.07.
| Current Ratio | 1.95 |
| Quick Ratio | 1.59 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | -0.03 |
| Debt / FCF | -0.04 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $51,421.88 |
| Profits Per Employee | $-239,343.75 |
| Employee Count | 64 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 0.93 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -1.69% in the last 52 weeks. The beta is 2.31, so IceCure Medical Ltd's price volatility has been higher than the market average.
| Beta | 2.31 |
| 52-Week Price Change | -1.69% |
| 50-Day Moving Average | 1.25 |
| 200-Day Moving Average | 0.94 |
| Relative Strength Index (RSI) | 46.67 |
| Average Volume (20 Days) | 307,975 |
Income Statement
In the last 12 months, IceCure Medical Ltd had revenue of 3.29M and earned -15.32M in profits. Earnings per share was -0.31.
| Revenue | 3.29M |
| Gross Profit | 1.45M |
| Operating Income | -15.7M |
| Net Income | -15.32M |
| EBITDA | -15.36M |
| EBIT | -15.7M |
| Earnings Per Share (EPS) | -0.31 |
Balance Sheet
The company has 7.56M in cash and 459K in debt, giving a net cash position of 7.11M.
| Cash & Cash Equivalents | 7.56M |
| Total Debt | 459K |
| Net Cash | 7.11M |
| Retained Earnings | -105.38M |
| Total Assets | 12.58M |
| Working Capital | 5.24M |
Cash Flow
In the last 12 months, operating cash flow was -12.56M and capital expenditures -71K, giving a free cash flow of -12.63M.
| Operating Cash Flow | -12.56M |
| Capital Expenditures | -71K |
| Free Cash Flow | -12.63M |
| FCF Per Share | -0.26 |
Margins
Gross margin is 44.09%, with operating and profit margins of -476.94% and -465.45%.
| Gross Margin | 44.09% |
| Operating Margin | -476.94% |
| Pretax Margin | -465.45% |
| Profit Margin | -465.45% |
| EBITDA Margin | -466.85% |
| EBIT Margin | -476.94% |
| FCF Margin | -383.9% |
Dividends & Yields
ICCM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ICCM is $2.5, which is 115.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.5 |
| Price Target Difference | 115.5% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Aug 9, 2021. It was a backward split with a ratio of 1:8.
| Last Split Date | Aug 9, 2021 |
| Split Type | backward |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | -7.79 |
| Piotroski F-Score | 3 |